DK3330271T3 - PYRROLO[2,3-d]PYRIMIDINFORBINDELSE ELLER SALT DERAF - Google Patents
PYRROLO[2,3-d]PYRIMIDINFORBINDELSE ELLER SALT DERAF Download PDFInfo
- Publication number
- DK3330271T3 DK3330271T3 DK16832927.4T DK16832927T DK3330271T3 DK 3330271 T3 DK3330271 T3 DK 3330271T3 DK 16832927 T DK16832927 T DK 16832927T DK 3330271 T3 DK3330271 T3 DK 3330271T3
- Authority
- DK
- Denmark
- Prior art keywords
- pyrimide
- pyrrolo
- salt
- compound
- pyrimide compound
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Transplantation (AREA)
- Inorganic Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2015152123 | 2015-07-31 | ||
PCT/JP2016/072258 WO2017022648A1 (ja) | 2015-07-31 | 2016-07-29 | ピロロ[2,3-d]ピリミジン化合物又はその塩 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK3330271T3 true DK3330271T3 (da) | 2022-11-14 |
Family
ID=57943140
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK16832927.4T DK3330271T3 (da) | 2015-07-31 | 2016-07-29 | PYRROLO[2,3-d]PYRIMIDINFORBINDELSE ELLER SALT DERAF |
Country Status (18)
Country | Link |
---|---|
US (1) | US10421760B2 (da) |
EP (1) | EP3330271B1 (da) |
JP (1) | JP6438585B2 (da) |
KR (1) | KR102086999B1 (da) |
CN (1) | CN107849052B (da) |
AU (1) | AU2016302302B2 (da) |
CA (1) | CA2989989C (da) |
DK (1) | DK3330271T3 (da) |
ES (1) | ES2927324T3 (da) |
HK (1) | HK1251232A1 (da) |
HU (1) | HUE060733T2 (da) |
MA (1) | MA42544A (da) |
MX (1) | MX2018001307A (da) |
PL (1) | PL3330271T3 (da) |
PT (1) | PT3330271T (da) |
RU (1) | RU2712269C2 (da) |
TW (1) | TWI716427B (da) |
WO (1) | WO2017022648A1 (da) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018210661A1 (en) * | 2017-05-15 | 2018-11-22 | Basf Se | Heteroaryl compounds as agrochemical fungicides |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PA8474101A1 (es) * | 1998-06-19 | 2000-09-29 | Pfizer Prod Inc | Compuestos de pirrolo [2,3-d] pirimidina |
KR20070104641A (ko) | 2005-02-03 | 2007-10-26 | 버텍스 파마슈티칼스 인코포레이티드 | 단백질 키나제의 억제제로 유용한 피롤로피리미딘 |
US8993756B2 (en) | 2011-12-06 | 2015-03-31 | Merck Sharp & Dohme Corp. | Pyrrolopyrimidines as janus kinase inhibitors |
JO3805B1 (ar) | 2013-10-10 | 2021-01-31 | Araxes Pharma Llc | مثبطات كراس جي12سي |
EP3055290B1 (en) * | 2013-10-10 | 2019-10-02 | Araxes Pharma LLC | Inhibitors of kras g12c |
US9676773B2 (en) * | 2014-02-04 | 2017-06-13 | Taiho Pharmaceutical Co., Ltd. | Azaindole derivative |
CN105732636B (zh) * | 2014-12-30 | 2020-04-21 | 广东东阳光药业有限公司 | 杂芳化合物及其在药物中的应用 |
-
2016
- 2016-07-29 TW TW105124172A patent/TWI716427B/zh active
- 2016-07-29 HU HUE16832927A patent/HUE060733T2/hu unknown
- 2016-07-29 KR KR1020187002320A patent/KR102086999B1/ko active IP Right Grant
- 2016-07-29 EP EP16832927.4A patent/EP3330271B1/en active Active
- 2016-07-29 PL PL16832927.4T patent/PL3330271T3/pl unknown
- 2016-07-29 DK DK16832927.4T patent/DK3330271T3/da active
- 2016-07-29 JP JP2017532562A patent/JP6438585B2/ja active Active
- 2016-07-29 CA CA2989989A patent/CA2989989C/en active Active
- 2016-07-29 ES ES16832927T patent/ES2927324T3/es active Active
- 2016-07-29 CN CN201680045029.9A patent/CN107849052B/zh active Active
- 2016-07-29 MA MA042544A patent/MA42544A/fr unknown
- 2016-07-29 MX MX2018001307A patent/MX2018001307A/es unknown
- 2016-07-29 US US15/746,208 patent/US10421760B2/en active Active
- 2016-07-29 AU AU2016302302A patent/AU2016302302B2/en active Active
- 2016-07-29 RU RU2018103360A patent/RU2712269C2/ru active
- 2016-07-29 WO PCT/JP2016/072258 patent/WO2017022648A1/ja active Application Filing
- 2016-07-29 PT PT168329274T patent/PT3330271T/pt unknown
-
2018
- 2018-08-22 HK HK18110790.1A patent/HK1251232A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
ES2927324T3 (es) | 2022-11-04 |
JPWO2017022648A1 (ja) | 2018-03-01 |
MX2018001307A (es) | 2018-05-22 |
AU2016302302A1 (en) | 2018-01-18 |
HK1251232A1 (zh) | 2019-01-25 |
EP3330271B1 (en) | 2022-09-07 |
CN107849052B (zh) | 2020-05-12 |
CN107849052A (zh) | 2018-03-27 |
BR112018001695A2 (pt) | 2018-09-18 |
KR20180030848A (ko) | 2018-03-26 |
HUE060733T2 (hu) | 2023-04-28 |
EP3330271A4 (en) | 2019-05-01 |
PT3330271T (pt) | 2022-09-29 |
MA42544A (fr) | 2018-06-06 |
RU2712269C2 (ru) | 2020-01-28 |
EP3330271A1 (en) | 2018-06-06 |
CA2989989A1 (en) | 2017-02-09 |
KR102086999B1 (ko) | 2020-03-10 |
RU2018103360A (ru) | 2019-08-29 |
WO2017022648A1 (ja) | 2017-02-09 |
JP6438585B2 (ja) | 2018-12-19 |
TW201713664A (zh) | 2017-04-16 |
US20180208598A1 (en) | 2018-07-26 |
AU2016302302B2 (en) | 2019-12-19 |
PL3330271T3 (pl) | 2022-12-19 |
TWI716427B (zh) | 2021-01-21 |
US10421760B2 (en) | 2019-09-24 |
RU2018103360A3 (da) | 2019-09-04 |
CA2989989C (en) | 2021-07-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1257146A1 (zh) | 新型的吡唑並[3,4-d]嘧啶化合物或其鹽 | |
EP3532069A4 (en) | ARYL-AMIDE PHOSPHODIAMIDE COMPOUNDS ANTIVIRALS | |
HK1254983A1 (zh) | 稠合嘧啶化合物或其鹽 | |
DK3360864T3 (da) | Pyrimidinforbindelse | |
EP3467335A4 (en) | THREE-DIMENSIONAL STRUCTURE | |
PT3466934T (pt) | Compostos de sulfonamida ou seus sais como inibidores da ribonucleótido-redutase para o tratamento de cancro | |
EP3355088A4 (en) | RETRO REFLECTOR | |
KR20180084876A (ko) | 내플라즈마성 부재 | |
EP3381916A4 (en) | CONDENSED PYRIMIDINE COMPOUND OR SALT THEREOF | |
GB201701939D0 (en) | Salt | |
EP3383869A4 (en) | ARYLSULFONAMIDES AS BLT1 ANTAGONISTS | |
DK3372589T3 (da) | Pyrimidinderivat | |
SG11201803584RA (en) | 1,4-dicarbonyl-piperidyl derivatives | |
HK1254800A1 (zh) | 2,3,4,5-四氫吡啶-6-胺衍生物 | |
EP3383868A4 (en) | ARYL SULFONAMIDES AS BLT1 ANTAGONISTS | |
IL254578A0 (en) | Abscisic acid (s)-2' vinyl derivatives | |
DK3330271T3 (da) | PYRROLO[2,3-d]PYRIMIDINFORBINDELSE ELLER SALT DERAF | |
FR3040615B1 (fr) | Robot de preparation culinaire | |
PL3564230T3 (pl) | Podstawione związki guanidyny | |
BR112018005298A2 (pt) | compostos com terminação [(2-etoxi-5-trans-1-propen-1-il)-fenoxil] | |
EP3489976A4 (en) | THREE DIMENSIONAL STRUCTURE | |
FR3048403B1 (fr) | Outillage de preparation de planches de bord | |
FR3033477B3 (fr) | Piece de bagage | |
EP3381901A4 (en) | DIARYLIODONIUM SALT CONTAINING PENTAFLUOROSULFANYLPYRIDYL GROUP | |
FR3041379B1 (fr) | Turbopropulseur d'aeronef |